{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:22:21Z","timestamp":1787908941019,"version":"build-2784847793"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017932","name":"Western University of Health Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017932","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hyperlipidemia (HYL) and hyperglycemia (HYG) directly drive pathological cardiac remodeling; however, the mechanisms by which these conditions differentially regulate profibrotic signaling and early stress\u2011response pathways in left ventricular (LV) myocardium remain poorly defined. This study investigated the expression and localization of galectin-3 (Gal-3), transforming growth factor-\u03b21 (TGF-\u03b21), and brain natriuretic peptide (BNP) in a Yucatan miniswine model of HYL and HYG. Female Yucatan miniswine were assigned to normal control, HYL (high-cholesterol diet), or HYG (high-fat\/high-carbohydrate diet plus low dose streptozotocin) groups (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20096\/group) for 8-weeks, and LV tissue was assessed by histology, qRT-PCR, Western blot, and immunohistochemistry. Both metabolic conditions induced cardiomyocyte hypertrophy and interstitial fibrosis, with more diffuse collagen deposition in HYG myocardium. qRT-PCR demonstrated upregulation of Gal-3, TGF-\u03b21, and BNP relative to controls, with transcript levels positively correlating with circulating glucose concentration. Western blot analysis showed relatively greater active TGF-\u03b21 signal in HYL myocardium and greater latent precursor accumulation in HYG myocardium, suggesting condition-associated differences in TGF-\u03b21 regulation. Immunohistochemistry demonstrated perivascular Gal-3 localization, cytoplasmic and perinuclear TGF-\u03b21 immunoreactivity in cardiomyocytes, and BNP immunoreactivity predominantly within subendocardial Purkinje fibers, with increased staining intensity in metabolically stressed groups compared with controls. Collectively, these findings suggest that HYL and HYG are associated with overlapping but distinct patterns of Gal-3, TGF-\u03b21, and BNP expression during metabolic cardiac remodeling. The Gal-3\/TGF-\u03b21 axis may represent a shared profibrotic pathway, whereas BNP may reflect a compensatory stress response whose functional significance requires further mechanistic validation.\n                  <\/jats:p>","DOI":"10.1007\/s11010-026-05620-z","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:55:06Z","timestamp":1782921306000},"page":"3695-3706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Galectin-3, transforming growth factor beta 1, and brain natriuretic peptide in cardiac remodeling under hyperlipidemic and hyperglycemic stress"],"prefix":"10.1007","volume":"481","author":[{"given":"Hina","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelie","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0011-4425","authenticated-orcid":false,"given":"Resmi","family":"Rajalekshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-0013","authenticated-orcid":false,"given":"Devendra K.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"5620_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jtcvs.2016.09.058","volume":"153","author":"DK Agrawal","year":"2017","unstructured":"Agrawal DK, Boosani CS (2017) Cellular reprogramming in cardiac diseases: a feather in the hat of regenerative medicine. J Thorac Cardiovasc Surg 153:327\u2013328. https:\/\/doi.org\/10.1016\/j.jtcvs.2016.09.058","journal-title":"J Thorac Cardiovasc Surg"},{"key":"5620_CR2","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s11010-020-03980-8","volume":"476","author":"SM Brown","year":"2021","unstructured":"Brown SM, Larsen NK, Thankam FG, Agrawal DK (2021) Fetal cardiomyocyte phenotype, ketone body metabolism, and mitochondrial dysfunction in the pathology of atrial fibrillation. Mol Cell Biochem 476:1165\u20131178. https:\/\/doi.org\/10.1007\/s11010-020-03980-8","journal-title":"Mol Cell Biochem"},{"key":"5620_CR3","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1093\/eurheartj\/ehx343","volume":"38","author":"E L\u00e1z\u00e1r","year":"2017","unstructured":"L\u00e1z\u00e1r E, Sadek HA, Bergmann O (2017) Cardiomyocyte renewal in the human heart: insights from the fall-out. Eur Heart J 38:2333\u20132342. https:\/\/doi.org\/10.1093\/eurheartj\/ehx343","journal-title":"Eur Heart J"},{"key":"5620_CR4","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","volume":"109","author":"N Frey","year":"2004","unstructured":"Frey N, Katus HA, Olson EN, Hill JA (2004) Hypertrophy of the Heart. Circulation 109:1580\u20131589. https:\/\/doi.org\/10.1161\/01.CIR.0000120390.68287.BB","journal-title":"Circulation"},{"key":"5620_CR5","doi-asserted-by":"publisher","first-page":"H587","DOI":"10.1152\/ajpheart.00588.2015","volume":"310","author":"A Ol\u00e1h","year":"2016","unstructured":"Ol\u00e1h A, N\u00e9meth BT, M\u00e1ty\u00e1s C et al (2016) Physiological and pathological left ventricular hypertrophy of comparable degree is associated with characteristic differences of in vivo hemodynamics. Am J Physiol Heart Circ Physiol 310:H587\u2013H597. https:\/\/doi.org\/10.1152\/ajpheart.00588.2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"5620_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-016-2849-0","volume":"424","author":"V Rai","year":"2017","unstructured":"Rai V, Sharma P, Agrawal S, Agrawal DK (2017) Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research. Mol Cell Biochem 424:123\u2013145. https:\/\/doi.org\/10.1007\/s11010-016-2849-0","journal-title":"Mol Cell Biochem"},{"key":"5620_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12265-018-9813-1","volume":"11","author":"JH Rosenberg","year":"2018","unstructured":"Rosenberg JH, Werner JH, Moulton MJ, Agrawal DK (2018) Current modalities and mechanisms underlying cardioprotection by ischemic conditioning. J Cardiovasc Transl Res 11:292\u2013307. https:\/\/doi.org\/10.1007\/s12265-018-9813-1","journal-title":"J Cardiovasc Transl Res"},{"key":"5620_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yexmp.2012.04.006","volume":"93","author":"GK Gupta","year":"2012","unstructured":"Gupta GK, Agrawal T, DelCore MG et al (2012) Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol 93:82\u201390. https:\/\/doi.org\/10.1016\/j.yexmp.2012.04.006","journal-title":"Exp Mol Pathol"},{"key":"5620_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.26502\/jppch.74050214","volume":"9","author":"G Gurumurthy","year":"2025","unstructured":"Gurumurthy G, Agrawal DK (2025) Impact of maternal ultra-processed food consumption and preterm birth on the development of metabolic disorders in offspring. J Pediatr Perinatol Child Health 9:68\u201384. https:\/\/doi.org\/10.26502\/jppch.74050214","journal-title":"J Pediatr Perinatol Child Health"},{"key":"5620_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","volume":"20","author":"TG Martin","year":"2023","unstructured":"Martin TG, Juarros MA, Leinwand LA (2023) Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential. Nat Rev Cardiol 20:347\u2013363. https:\/\/doi.org\/10.1038\/s41569-022-00806-6","journal-title":"Nat Rev Cardiol"},{"key":"5620_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.120.051264","volume":"143","author":"Y Yang","year":"2021","unstructured":"Yang Y, Kurian J, Schena G et al (2021) Cardiac remodeling during pregnancy with metabolic syndrome. Circulation 143:699\u2013712. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051264","journal-title":"Circulation"},{"key":"5620_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131780","volume":"12","author":"F Bazgir","year":"2023","unstructured":"Bazgir F, Nau J, Nakhaei-Rad S et al (2023) The microenvironment of the pathogenesis of cardiac hypertrophy. Cells 12:1780. https:\/\/doi.org\/10.3390\/cells12131780","journal-title":"Cells"},{"key":"5620_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084195","volume":"23","author":"J Kruszewska","year":"2022","unstructured":"Kruszewska J, Cudnoch-Jedrzejewska A, Czarzasta K (2022) Remodeling and fibrosis of the cardiac muscle in the course of obesity\u2014pathogenesis and involvement of the extracellular matrix. Int J Mol Sci 23:4195. https:\/\/doi.org\/10.3390\/ijms23084195","journal-title":"Int J Mol Sci"},{"key":"5620_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.26502\/fccm.92920466","volume":"9","author":"S Patel","year":"2025","unstructured":"Patel S, Patel H, Mukadam S, Agrawal DK (2025) Apolipoprotein B in the risk assessment, diagnosis, and treatment of cardiometabolic diseases. Cardiol Cardiovasc Med 9:427\u2013438. https:\/\/doi.org\/10.26502\/fccm.92920466","journal-title":"Cardiol Cardiovasc Med"},{"key":"5620_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.26502\/aimr.0184","volume":"7","author":"R Patial","year":"2024","unstructured":"Patial R, Batta I, Thakur M et al (2024) Etiology, pathophysiology, and treatment strategies in the prevention and management of metabolic syndrome. Arch Intern Med Res 7:273\u2013283. https:\/\/doi.org\/10.26502\/aimr.0184","journal-title":"Arch Intern Med Res"},{"key":"5620_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/14779072.2019.1562902","volume":"17","author":"JH Rosenberg","year":"2019","unstructured":"Rosenberg JH, Werner JH, Plitt GD et al (2019) Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation. Expert Rev Cardiovasc Ther 17:193\u2013207. https:\/\/doi.org\/10.1080\/14779072.2019.1562902","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"5620_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00238","volume":"8","author":"T Liu","year":"2017","unstructured":"Liu T, Song D, Dong J et al (2017) Current understanding of the pathophysiology of myocardial fibrosis and its quantitative assessment in heart failure. Front Physiol 8:238. https:\/\/doi.org\/10.3389\/fphys.2017.00238","journal-title":"Front Physiol"},{"key":"5620_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10741-016-9536-9","volume":"21","author":"A Piek","year":"2016","unstructured":"Piek A, de Boer RA, Sillj\u00e9 HHW (2016) The fibrosis-cell death axis in heart failure. Heart Fail Rev 21:199\u2013211. https:\/\/doi.org\/10.1007\/s10741-016-9536-9","journal-title":"Heart Fail Rev"},{"key":"5620_CR19","doi-asserted-by":"publisher","DOI":"10.26502\/aimr.0169","author":"G Shanmuganathan","year":"2024","unstructured":"Shanmuganathan G, Agrawal D (2024) Diabetes and abdominal aortic aneurysm: is the protective effect on AAA due to antidiabetic medications alone, due to the disease alone, or both? Arch Intern Med. https:\/\/doi.org\/10.26502\/aimr.0169","journal-title":"Arch Intern Med"},{"key":"5620_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00395-025-01112-1","volume":"120","author":"X-L Tang","year":"2025","unstructured":"Tang X-L, Alloosh M, Ou Q et al (2025) A new model of heart failure with preserved ejection fraction induced by metabolic syndrome in Ossabaw miniature swine. Basic Res Cardiol 120:559\u2013578. https:\/\/doi.org\/10.1007\/s00395-025-01112-1","journal-title":"Basic Res Cardiol"},{"key":"5620_CR21","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1172\/JCI87491","volume":"127","author":"NG Frangogiannis","year":"2017","unstructured":"Frangogiannis NG (2017) The extracellular matrix in myocardial injury, repair, and remodeling. J Clin Invest 127:1600\u20131612. https:\/\/doi.org\/10.1172\/JCI87491","journal-title":"J Clin Invest"},{"key":"5620_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.621644","volume":"8","author":"AC Silva","year":"2021","unstructured":"Silva AC, Pereira C, Fonseca ACRG et al (2021) Bearing my heart: the role of extracellular matrix on cardiac development, homeostasis, and injury response. Front Cell Dev Biol 8:621644. https:\/\/doi.org\/10.3389\/fcell.2020.621644","journal-title":"Front Cell Dev Biol"},{"key":"5620_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.26502\/fccm.92920302","volume":"7","author":"D Singh","year":"2023","unstructured":"Singh D, Rai V, Agrawal DK (2023) Regulation of collagen I and collagen III in tissue injury and regeneration. Cardiol Cardiovasc Med 7:5\u201316. https:\/\/doi.org\/10.26502\/fccm.92920302","journal-title":"Cardiol Cardiovasc Med"},{"key":"5620_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12040297","volume":"12","author":"A Nikolov","year":"2022","unstructured":"Nikolov A, Popovski N (2022) Extracellular matrix in heart disease: focus on circulating collagen type I and III derived peptides as biomarkers of myocardial fibrosis and their potential in the prognosis of heart failure: a concise review. Metabolites 12:297. https:\/\/doi.org\/10.3390\/metabo12040297","journal-title":"Metabolites"},{"key":"5620_CR25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.81264","volume":"17","author":"HA BaniHani","year":"2025","unstructured":"BaniHani HA, Khaled LH, Al Sharaa NM et al (2025) Causes, diagnosis, treatment, and prognosis of cardiac fibrosis: a systematic review. Cureus 17:e81264. https:\/\/doi.org\/10.7759\/cureus.81264","journal-title":"Cureus"},{"key":"5620_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.trsl.2018.07.012","volume":"203","author":"JH Werner","year":"2019","unstructured":"Werner JH, Rosenberg JH, Um JY et al (2019) Molecular discoveries and treatment strategies by direct reprogramming in cardiac regeneration. Transl Res 203:73\u201387. https:\/\/doi.org\/10.1016\/j.trsl.2018.07.012","journal-title":"Transl Res"},{"key":"5620_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118385","volume":"190","author":"L Flori","year":"2025","unstructured":"Flori L, Calderone V, Testai L (2025) Emerging role of the cardiac lipidome in the progression of heart failure. Biomed Pharmacother 190:118385. https:\/\/doi.org\/10.1016\/j.biopha.2025.118385","journal-title":"Biomed Pharmacother"},{"key":"5620_CR28","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1194\/jlr.R001115","volume":"50","author":"PC Schulze","year":"2009","unstructured":"Schulze PC (2009) Myocardial lipid accumulation and lipotoxicity in heart failure. J Lipid Res 50:2137\u20132138. https:\/\/doi.org\/10.1194\/jlr.R001115","journal-title":"J Lipid Res"},{"key":"5620_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.trsl.2022.10.004","volume":"254","author":"FG Thankam","year":"2023","unstructured":"Thankam FG, Sedighim S, Kuan R, Agrawal DK (2023) Ischemia challenged epicardial adipose tissue stem cells-derived extracellular vesicles alter the gene expression of cardiac fibroblasts to cardiomyocyte like phenotype. Transl Res 254:54\u201367. https:\/\/doi.org\/10.1016\/j.trsl.2022.10.004","journal-title":"Transl Res"},{"key":"5620_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-1171-8","volume":"19","author":"YS Yao","year":"2020","unstructured":"Yao YS, Li TD, Zeng ZH (2020) Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review. Lipids Health Dis 19:23. https:\/\/doi.org\/10.1186\/s12944-019-1171-8","journal-title":"Lipids Health Dis"},{"issue":"1","key":"5620_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40842-025-00247-3","volume":"11","author":"A Hussain","year":"2025","unstructured":"Hussain A (2025) Chronic hyperglycemia and cardiovascular dysfunction: an in-depth exploration of metabolic and cellular pathways in type 2 diabetes mellitus. Cardiovasc Diabetol 11:39. https:\/\/doi.org\/10.1186\/s40842-025-00247-3","journal-title":"Cardiovasc Diabetol"},{"key":"5620_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1092148","author":"C Li","year":"2023","unstructured":"Li C, Meng X, Wang L, Dai X (2023) Mechanism of action of non-coding RNAs and traditional Chinese medicine in myocardial fibrosis: focus on the TGF-\u03b2\/Smad signaling pathway. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1092148","journal-title":"Front Pharmacol"},{"key":"5620_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11897-010-0004-x","volume":"7","author":"RA de Boer","year":"2010","unstructured":"de Boer RA, Yu L, van Veldhuisen DJ (2010) Galectin-3 in cardiac remodeling and heart failure. Curr Heart Fail Rep 7:1\u20138. https:\/\/doi.org\/10.1007\/s11897-010-0004-x","journal-title":"Curr Heart Fail Rep"},{"key":"5620_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107300","volume":"300","author":"JF Calver","year":"2024","unstructured":"Calver JF, Parmar NR, Harris G et al (2024) Defining the mechanism of galectin-3\u2013mediated TGF-\u03b21 activation and its role in lung fibrosis. J Biol Chem 300:107300. https:\/\/doi.org\/10.1016\/j.jbc.2024.107300","journal-title":"J Biol Chem"},{"key":"5620_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1159\/000506072","volume":"145","author":"M Xiao","year":"2020","unstructured":"Xiao M, Zhang M, Bie M et al (2020) Galectin-3 induces atrial fibrosis by activating the TGF-\u03b21\/Smad pathway in patients with atrial fibrillation. Cardiology 145:446\u2013455. https:\/\/doi.org\/10.1159\/000506072","journal-title":"Cardiology"},{"key":"5620_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.691407","author":"GJJ da Silva","year":"2021","unstructured":"da Silva GJJ, Altara R, Booz GW, Cataliotti A (2021) Atrial natriuretic peptide31\u201367: a novel therapeutic factor for cardiovascular diseases. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2021.691407","journal-title":"Front Physiol"},{"key":"5620_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214415","volume":"23","author":"R Sarzani","year":"2022","unstructured":"Sarzani R, Allevi M, Di Pentima C et al (2022) Role of cardiac natriuretic peptides in heart structure and function. Int J Mol Sci 23:14415. https:\/\/doi.org\/10.3390\/ijms232214415","journal-title":"Int J Mol Sci"},{"key":"5620_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e41157","volume":"11","author":"X Wang","year":"2024","unstructured":"Wang X, Yu S, Xie L et al (2024) The role of the extracellular matrix in cardiac regeneration. Heliyon 11:e41157. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e41157","journal-title":"Heliyon"},{"key":"5620_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","volume":"127","author":"AA Gibb","year":"2020","unstructured":"Gibb AA, Lazaropoulos MP, Elrod JW (2020) Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation. Circ Res 127:427\u2013447. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316958","journal-title":"Circ Res"},{"key":"5620_CR40","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbadis.2016.11.006","volume":"1863","author":"AV Shinde","year":"2017","unstructured":"Shinde AV, Humeres C, Frangogiannis NG (2017) The role of \u03b1-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta Mol Basis Dis 1863:298\u2013309. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.006","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5620_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052719","volume":"23","author":"M Gaggini","year":"2022","unstructured":"Gaggini M, Ndreu R, Michelucci E et al (2022) Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease. Int J Mol Sci 23:2719. https:\/\/doi.org\/10.3390\/ijms23052719","journal-title":"Int J Mol Sci"},{"key":"5620_CR42","doi-asserted-by":"publisher","first-page":"e937051-1","DOI":"10.12659\/MSM.937051","volume":"28","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wu H, Wang T et al (2022) Mechanisms of myocardial damage due to hyperlipidemia: a review of recent studies. Med Sci Monit 28:e937051-1-e937051-9. https:\/\/doi.org\/10.12659\/MSM.937051","journal-title":"Med Sci Monit"},{"key":"5620_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02401-w","volume":"11","author":"L Zhao","year":"2026","unstructured":"Zhao L, Yuan J, Yang Q et al (2026) Diabetes and its complications: molecular mechanisms, prevention and treatment. Sig Transduct Target Ther 11:22. https:\/\/doi.org\/10.1038\/s41392-025-02401-w","journal-title":"Sig Transduct Target Ther"},{"key":"5620_CR44","doi-asserted-by":"publisher","first-page":"eadn6052","DOI":"10.1126\/scisignal.adn6052","volume":"17","author":"JW Jackson","year":"2024","unstructured":"Jackson JW, Frederick C, Pal A et al (2024) An antibody that inhibits TGF-\u03b21 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis. Sci Signal 17:eadn6052. https:\/\/doi.org\/10.1126\/scisignal.adn6052","journal-title":"Sci Signal"},{"key":"5620_CR45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/15548627.2017.1422850","volume":"14","author":"J N\u00fcchel","year":"2018","unstructured":"N\u00fcchel J, Ghatak S, Zuk AV et al (2018) TGFB1 is secreted through an unconventional pathway dependent on the autophagic machinery and cytoskeletal regulators. Autophagy 14:465\u2013486. https:\/\/doi.org\/10.1080\/15548627.2017.1422850","journal-title":"Autophagy"},{"key":"5620_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109826","volume":"77","author":"A Hanna","year":"2021","unstructured":"Hanna A, Humeres C, Frangogiannis NG (2021) The role of Smad signaling cascades in cardiac fibrosis. Cell Signal 77:109826. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109826","journal-title":"Cell Signal"},{"key":"5620_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.588347","volume":"7","author":"S Saadat","year":"2020","unstructured":"Saadat S, Noureddini M, Mahjoubin-Tehran M et al (2020) Pivotal role of TGF-\u03b2\/Smad signaling in cardiac fibrosis: non-coding RNAs as effectual players. Front Cardiovasc Med 7:588347. https:\/\/doi.org\/10.3389\/fcvm.2020.588347","journal-title":"Front Cardiovasc Med"},{"key":"5620_CR48","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","volume":"6","author":"R-M Liu","year":"2015","unstructured":"Liu R-M, Desai LP (2015) Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: a perverse cycle for fibrosis. Redox Biol 6:565\u2013577. https:\/\/doi.org\/10.1016\/j.redox.2015.09.009","journal-title":"Redox Biol"},{"key":"5620_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1083\/jcb.200606058","volume":"175","author":"G Ge","year":"2006","unstructured":"Ge G, Greenspan DS (2006) BMP1 controls TGF\u03b21 activation via cleavage of latent TGF\u03b2-binding protein. J Cell Biol 175:111\u2013120. https:\/\/doi.org\/10.1083\/jcb.200606058","journal-title":"J Cell Biol"},{"key":"5620_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6809703","author":"AM Kay","year":"2016","unstructured":"Kay AM, Simpson CL, Stewart JA (2016) The role of AGE\/RAGE signaling in diabetes-mediated vascular calcification. J Diabetes Res 8. https:\/\/doi.org\/10.1155\/2016\/6809703","journal-title":"J Diabetes Res"},{"key":"5620_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118756","volume":"193","author":"A Sedl\u00e1\u0159","year":"2025","unstructured":"Sedl\u00e1\u0159 A, Bojarov\u00e1 P, Kol\u00e1\u0159 F et al (2025) Galectin-3 as a therapeutic target in pulmonary hypertension: molecular mechanisms, drug development directions, and emerging clinical applications. Biomed Pharmacother 193:118756. https:\/\/doi.org\/10.1016\/j.biopha.2025.118756","journal-title":"Biomed Pharmacother"},{"key":"5620_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1070973","author":"X Yin","year":"2023","unstructured":"Yin X, Yin X, Pan X et al (2023) Post-myocardial infarction fibrosis: pathophysiology, examination, and intervention. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1070973","journal-title":"Front Pharmacol"},{"key":"5620_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jacbts.2016.03.003","volume":"1","author":"Y Takemoto","year":"2016","unstructured":"Takemoto Y, Ramirez RJ, Yokokawa M et al (2016) Galectin-3 regulates atrial fibrillation remodeling and predicts catheter ablation outcomes. JACC Basic Transl Sci 1:143\u2013154. https:\/\/doi.org\/10.1016\/j.jacbts.2016.03.003","journal-title":"JACC Basic Transl Sci"},{"key":"5620_CR54","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1016\/j.jacc.2017.11.010","volume":"70","author":"AG Almeida","year":"2017","unstructured":"Almeida AG (2017) <article-title update=\"added\">NT-proBNP and myocardial fibrosis. J Am Coll Cardiol 70:3110\u20133112. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.010","journal-title":"J Am Coll Cardiol"},{"key":"5620_CR55","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002423","volume":"4","author":"R Kerkel\u00e4","year":"2015","unstructured":"Kerkel\u00e4 R, Ulvila J, Magga J (2015) Natriuretic peptides in the regulation of cardiovascular physiology and metabolic events. J Am Heart Assoc 4:e002423. https:\/\/doi.org\/10.1161\/JAHA.115.002423","journal-title":"J Am Heart Assoc"},{"key":"5620_CR56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/01.RES.0000117070.86556.9F","volume":"94","author":"AM Kapoun","year":"2004","unstructured":"Kapoun AM, Liang F, O\u2019Young G et al (2004) B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 94:453\u2013461. https:\/\/doi.org\/10.1161\/01.RES.0000117070.86556.9F","journal-title":"Circ Res"},{"key":"5620_CR57","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.52559-2020","author":"Society ER","year":"2022","unstructured":"Society ER (2022) Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.\u201d Nikhil Hirani, Alison C. MacKinnon, Lisa Nicol, et al. Eur Respir J 2021; 57: 2002559. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.52559-2020","journal-title":"Eur Respir J"},{"key":"5620_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.754499","volume":"8","author":"D Pascual-Figal","year":"2021","unstructured":"Pascual-Figal D, Bay\u00e9s-Genis A, Beltr\u00e1n-Troncoso P et al (2021) Sacubitril-valsartan, clinical benefits and related mechanisms of action in heart failure with reduced ejection fraction. A review. Front Cardiovasc Med 8:754499. https:\/\/doi.org\/10.3389\/fcvm.2021.754499","journal-title":"Front Cardiovasc Med"},{"key":"5620_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2021.103321","volume":"70","author":"GGC Pozder","year":"2022","unstructured":"Pozder GGC, van der Velde AR, Meijers WC et al (2022) Pectins from various sources inhibit galectin-3-related cardiac fibrosis. Curr Res Transl Med 70:103321. https:\/\/doi.org\/10.1016\/j.retram.2021.103321","journal-title":"Curr Res Transl Med"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05620-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05620-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05620-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:14:50Z","timestamp":1787908490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05620-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5620"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05620-z","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. DK Agrawal is currently serving as a section editor of the Molecular and Cellular Biochemistry journal.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}